Drug recall · March 24, 2021
Omeprazole Delayed-Release Capsules recall
Why: Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Omeprazole Delayed-Release Capsules, USP, 20 mg, 1000 count bottles, Rx Only, distributed by Breckenridge Pharmaceutical, Inc., Berlin, CT, Manufactured by Tow Pharmaceutical Europe, S.L., Martorelles (Barcelona), Spain NDC 51991-643-10
- Lots / codes
Lot # 191659, exp. date 05/2021
- Quantity
- 3,146 bottles
- Company
- Breckenridge Pharmaceutical, Inc, Berlin, CT
- Distribution
- Product was distributed nationwide
- Initiated
- March 11, 2021 · Voluntary: Firm initiated
- Classified
- March 18, 2021
- Reported
- March 24, 2021
- Ended
- March 23, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Omeprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.